Bryan M Burt1, Andrew W ElBardissi2, Robert S Huckman3, Lawrence H Cohn2, Marisa W Cevasco2, James D Rawn2, Sary F Aranki2, John G Byrne4. 1. Division of Thoracic Surgery, Department of Surgery, Baylor College of Medicine, Houston, Tex. 2. Division of Cardiac Surgery, Department of Surgery, The Brigham and Women's Hospital, Boston, Mass. 3. Harvard Business School, Harvard University, Boston, Mass. 4. Division of Cardiac Surgery, Department of Surgery, The Brigham and Women's Hospital, Boston, Mass. Electronic address: jbyrne@partners.org.
Abstract
OBJECTIVE: We hypothesized that increased postgraduate surgical experience correlates with improved operative efficiency and long-term survival in standard cardiac surgery procedures. METHODS: Utilizing a prospectively collected retrospective database, we identified patients who underwent isolated coronary artery bypass grafting (CABG) (n = 3726), aortic valve replacement (AVR) (n = 1626), mitral valve repair (n = 731), mitral valve replacement (MVR) (n = 324), and MVR + AVR (n = 184) from January 2002 through June 2012. After adjusting for patient risk and surgeon variability, we evaluated the influence of surgeon experience on cardiopulmonary bypass and crossclamp times, and long-term survival. RESULTS: Mean surgeon experience after fellowship graduation was 16.0 ± 11.7 years (range, 1.0-35.2 years). After adjusting for patient risk and surgeon-level fixed effects, learning curve analyses demonstrated improvements in cardiopulmonary bypass and crossclamp times with increased surgeon experience. There was marginal improvement in the predictability (R(2) value) of cardiopulmonary bypass and crossclamp time for CABG with the addition of surgeon experience; however, all other procedures had marked increases in the R(2) following addition of surgeon experience. Cox proportional hazard models revealed that increased surgeon experience was associated with improved long-term survival in AVR (hazard ratio [HR], 0.85; P < .0001), mitral valve repair (HR, 0.73; P < .0001), and MVR + AVR (HR, 0.95; P = .006) but not in CABG (HR, 0.80; P = .15), and a trend toward significance in MVR (HR, 0.87; P = .09). CONCLUSIONS: In cardiac surgery, not including CABG, surgeon experience is an important determinant of operative efficiency and of long-term survival.
OBJECTIVE: We hypothesized that increased postgraduate surgical experience correlates with improved operative efficiency and long-term survival in standard cardiac surgery procedures. METHODS: Utilizing a prospectively collected retrospective database, we identified patients who underwent isolated coronary artery bypass grafting (CABG) (n = 3726), aortic valve replacement (AVR) (n = 1626), mitral valve repair (n = 731), mitral valve replacement (MVR) (n = 324), and MVR + AVR (n = 184) from January 2002 through June 2012. After adjusting for patient risk and surgeon variability, we evaluated the influence of surgeon experience on cardiopulmonary bypass and crossclamp times, and long-term survival. RESULTS: Mean surgeon experience after fellowship graduation was 16.0 ± 11.7 years (range, 1.0-35.2 years). After adjusting for patient risk and surgeon-level fixed effects, learning curve analyses demonstrated improvements in cardiopulmonary bypass and crossclamp times with increased surgeon experience. There was marginal improvement in the predictability (R(2) value) of cardiopulmonary bypass and crossclamp time for CABG with the addition of surgeon experience; however, all other procedures had marked increases in the R(2) following addition of surgeon experience. Cox proportional hazard models revealed that increased surgeon experience was associated with improved long-term survival in AVR (hazard ratio [HR], 0.85; P < .0001), mitral valve repair (HR, 0.73; P < .0001), and MVR + AVR (HR, 0.95; P = .006) but not in CABG (HR, 0.80; P = .15), and a trend toward significance in MVR (HR, 0.87; P = .09). CONCLUSIONS: In cardiac surgery, not including CABG, surgeon experience is an important determinant of operative efficiency and of long-term survival.
Authors: Jef Van den Eynde; Hannah Vaesen Bentein; Tom Decaluwé; Herbert De Praetere; MaryAnn C Wertan; Francis P Sutter; Husam H Balkhy; Wouter Oosterlinck Journal: J Thorac Dis Date: 2021-07 Impact factor: 2.895
Authors: Alexandr V Bogachev-Prokophiev; Alexandr V Afanasyev; Sergei I Zheleznev; Vladimir M Nazarov; Ravil M Sharifulin; Alexandr M Karaskov Journal: J Cardiothorac Surg Date: 2017-12-13 Impact factor: 1.637
Authors: Joseph R Nellis; Mani A Daneshmand; Jeffrey G Gaca; Nicholas D Andersen; John C Haney; Joseph W Turek Journal: J Thorac Dis Date: 2021-10 Impact factor: 2.895
Authors: Lauren V Huckaby; Thomas G Gleason; Francis D Ferdinand; Ibrahim Sultan; Danny Chu; Pyongsoo Yoon; Forozan Navid; Siva Venkata; David West; Claudio Lima; Victor Morell; Shangzhen Chen; Floyd Thoma; Sasha Drew; Arman Kilic Journal: Ann Thorac Surg Date: 2020-10-27 Impact factor: 4.330
Authors: Hunaid A Vohra; M Yousuf Salmasi; Lueh Chien; Max Baghai; Ranjit Deshpande; Enoch Akowuah; Ishtiaq Ahmed; Michael Tolan; Toufan Bahrami; Steven Hunter; Joseph Zacharias Journal: Open Heart Date: 2020-10